Associate Director, Translational Medicine Expert, TM Clinical Pharmacology

Key Responsibilities

1.     Clinical Pharmacology Portfolio Leadership

·        Lead and manage multiple FiH and Clinical Pharmacology studies simultaneously with medical, scientific, and operational excellence

·        Provide expert Clinical Pharmacology input into Study Concept Sheets, protocols, Informed Consent Forms, Statistical Analysis Plans, and TLF shells

·        Oversee medical and safety aspects of studies, including Site Initiation Visits, ongoing safety reviews, medical coding, and safety reporting

·        Drive development of Clinical Study Reports and contribute to dissemination of study results (e.g., abstracts, posters, manuscripts, plain‑language and technical summaries)

2.     Clinical Pharmacology Strategy & Cross‑Functional Collaboration

·        Provide strategic Clinical Pharmacology guidance to ensure optimal study design aligned with program objectives

·        Partner with project‑level TMEs to align on compound background and program strategy

·        Lead or contribute to strategic initiatives, process optimization, and capability‑building efforts within TM Clinical Pharmacology

·        Strengthen collaborations with internal stakeholders across early and full development, as well as with external CRO partners

Impact of the Role

This role significantly influences the success of the Novartis development pipeline by:

·        Enabling efficient and high‑quality execution of FiH and Clinical Pharmacology studies

·        Delivering key data supporting program milestones and regulatory submissions

·        Strengthening Clinical Pharmacology as a Novartis Center of Excellence across all BR therapeutic areas

·        Elevating scientific and medical expertise within TM and across development teams

Essential Requirements

·        Medical degree (MD) combined with a PhD/post‑doctoral training, board certification, or relevant Clinical Pharmacology research experience

·        Significant experience in FiH and Clinical Pharmacology studies—either in biotech/pharma, as a PI/sub‑investigator at a CRO, or at an academic medical center

·        Proven track record of contributions to drug development, regulatory submissions, or high‑quality scientific publications

·        Experience within a TM therapeutic area is an asset

·        Full professional proficiency in English (spoken and written)